journal article·2026-07-01

Zein‐Ceria Hybrid Microparticles Enable Long‐Term ROS‐Scavenging Oxygenation for Osteogenic Microtissues Engineering

Hayeon Byun, Seok Gyu Han, Niels Willemen, Eunji Park, Kannan Govindaraj, Seol‐Ha Jeong, Oju Jeon, Eben Alsberg, Jeroen Leijten, Heungsoo Shin, Su Ryon Shin

Publisher page

Abstract

ABSTRACT Oxygen‐ and biological cue‐deprived microenvironments formed during tissue regeneration severely limit cell survival and differentiation, resulting in long‐term structural and functional deficits. However, conventional oxygen‐releasing biomaterials often exhibit burst releases, with the vast majority of oxygen released during the first few days, which is associated with high levels of concomitant reactive oxygen species (ROS)‐derived oxidative stress and a lack of bioactive factors. Here, we report a hierarchically engineered zein‐ceria hybrid microparticle that enables sustained ROS‐neutral oxygenation for over 40 days and supplies an osteoinductive factor. A hydrophobic zein core stabilizes the oxygen source and suppresses burst release, while a ceria nanozyme‐integrated shell continuously scavenges excess ROS via redox cycling. Biocompatible surface engineering enables the seamless integration of these microparticles within stem cell spheroids, which markedly enhances cell survival under anoxia. Their biofunctional surface supports enzymatic protein immobilization under physiological conditions, enabling spontaneous osteogenesis of engineered bone microtissues. In a severely oxygen‐deprived mouse calvarial defect model, the engineered microtissues accelerated bone regeneration. Our biomaterial design enables control of burst oxygen release, ROS modulation, and growth factor release, built on a zein‐ceria double‐layer architecture, offering a modular platform that broadens the utility of oxygenating and bioactive micromaterials in regenerative medicine.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Engineering in Medicine Department of Medicine Harvard Medical School and Brigham and Women's Hospital Cambridge Massachusetts USA

Leijten Laboratory Department of Bioengineering Technologies Faculty of Science and Technology TechMed Centre University Twente Enschede Netherlands

Department of Bioengineering Hanyang University Seoul Republic of Korea

BK21 FOUR Education and Research Group for Biopharmaceutical Innovation Leader Hanyang University Seoul Republic of Korea

Department of Biomedical Engineering University of Illinois Chicago Chicago Illinois USA

Departments of Orthopaedic Surgery Pharmacology and Regenerative Medicine, and Mechanical and Industrial Engineering University of Illinois Chicago Chicago Illinois USA

Jesse Brown Veterans Affairs Medical Center (JBVAMC) Chicago Illinois USA

Institute of Nano Science and Technology Hanyang University Seoul Republic of Korea

Funding

National Institutes of Health · National Research Foundation of Korea

References (76)

Show source-provided references
1. 10.1063/5.022580710.1063/5.0225807 ↗
2. 10.1038/srep1511610.1038/srep15116 ↗
3. 10.1002/adfm.20230855210.1002/adfm.202308552 ↗
4. 10.1038/s41536‐021‐00133‐310.1038/s41536‐021‐00133‐3 ↗
5. 10.1038/s41467‐023‐42297‐010.1038/s41467‐023‐42297‐0 ↗
6. 10.1038/s41467‐024‐48719‐x10.1038/s41467‐024‐48719‐x ↗
7. 10.1089/ten.teb.2009.008510.1089/ten.teb.2009.0085 ↗
8. 10.1038/nrm313210.1038/nrm3132 ↗
9. 10.1038/nmat244110.1038/nmat2441 ↗
10. 10.1002/jor.2151710.1002/jor.21517 ↗
11. 10.1016/S0014‐4827(02)00027‐710.1016/S0014‐4827(02)00027‐7 ↗
12. 10.1016/j.jtbi.2014.10.01210.1016/j.jtbi.2014.10.012 ↗
13. 10.1016/j.tibtech.2021.01.00710.1016/j.tibtech.2021.01.007 ↗
14. 10.1038/s41427‐019‐0166‐210.1038/s41427‐019‐0166‐2 ↗
15. 10.1016/j.biomaterials.2007.07.00310.1016/j.biomaterials.2007.07.003 ↗
16. 10.1016/j.tibtech.2016.05.01210.1016/j.tibtech.2016.05.012 ↗
17. 10.1016/j.indcrop.2022.11525010.1016/j.indcrop.2022.115250 ↗
18. 10.1080/00914037.2024.237438110.1080/00914037.2024.2374381 ↗
19. 10.1016/j.jddst.2022.10393710.1016/j.jddst.2022.103937 ↗
20. 10.1016/j.ijpharm.2021.12067310.1016/j.ijpharm.2021.120673 ↗
21. 10.1016/j.mtadv.2022.10030710.1016/j.mtadv.2022.100307 ↗
22. 10.1016/j.msec.2018.08.01010.1016/j.msec.2018.08.010 ↗
23. 10.1515/rams‐2022‐030810.1515/rams‐2022‐0308 ↗
24. 10.1038/s41580‐022‐00456‐z10.1038/s41580‐022‐00456‐z ↗
25. 10.2478/pjct‐2014‐007310.2478/pjct‐2014‐0073 ↗
26. 10.1172/JCI11121010.1172/JCI111210 ↗
27. 10.1002/adhm.20210269710.1002/adhm.202102697 ↗
28. 10.1002/adma.20180536810.1002/adma.201805368 ↗
29. 10.1016/j.jre.2023.04.00910.1016/j.jre.2023.04.009 ↗
30. 10.1016/j.jconrel.2015.04.02310.1016/j.jconrel.2015.04.023 ↗
31. 10.1177/0963689724127673310.1177/09636897241276733 ↗
32. 10.1007/s10544‐014‐9915‐810.1007/s10544‐014‐9915‐8 ↗
33. 10.1038/s43246‐022‐00309‐410.1038/s43246‐022‐00309‐4 ↗
34. 10.1039/D0TB01559H10.1039/D0TB01559H ↗
35. 10.3389/fimmu.2020.60794510.3389/fimmu.2020.607945 ↗
36. 10.1007/s13346‐022‐01143‐410.1007/s13346‐022‐01143‐4 ↗
37. 10.1021/jacsau.2c0021510.1021/jacsau.2c00215 ↗
38. 10.1016/j.compositesb.2021.10865510.1016/j.compositesb.2021.108655 ↗
39. 10.1016/j.saa.2007.06.03610.1016/j.saa.2007.06.036 ↗
40. 10.1039/D0BM00187B10.1039/D0BM00187B ↗
41. 10.1016/j.jallcom.2009.03.12510.1016/j.jallcom.2009.03.125 ↗
42. 10.1038/s41598‐020‐78550‐510.1038/s41598‐020‐78550‐5 ↗
43. 10.1007/s10311‐024‐01714‐610.1007/s10311‐024‐01714‐6 ↗
44. 10.1208/s12249‐010‐9565‐y10.1208/s12249‐010‐9565‐y ↗
45. 10.1007/s10853‐021‐06338‐710.1007/s10853‐021‐06338‐7 ↗
46. 10.1016/S0021‐9258(19)42185‐610.1016/S0021‐9258(19)42185‐6 ↗
47. 10.1021/jacsau.5c0009510.1021/jacsau.5c00095 ↗
48. 10.1016/j.biomaterials.2013.10.02210.1016/j.biomaterials.2013.10.022 ↗
49. 10.1016/j.lfs.2025.12356510.1016/j.lfs.2025.123565 ↗
50. 10.1002/adhm.20200060810.1002/adhm.202000608 ↗
51. 10.1021/acsbiomaterials.5b0027710.1021/acsbiomaterials.5b00277 ↗
52. 10.1089/ten.tea.2012.055110.1089/ten.tea.2012.0551 ↗
53. 10.1038/s41392‐023‐01332‐810.1038/s41392‐023‐01332‐8 ↗
54. 10.1088/1758‐5090/ad1cf210.1088/1758‐5090/ad1cf2 ↗
55. 10.1016/j.tibtech.2016.08.00410.1016/j.tibtech.2016.08.004 ↗
56. 10.1016/j.actbio.2022.09.05210.1016/j.actbio.2022.09.052 ↗
57. 10.1016/j.biomaterials.2011.02.02910.1016/j.biomaterials.2011.02.029 ↗
58. 10.1038/s41598‐022‐23650‐710.1038/s41598‐022‐23650‐7 ↗
59. 10.1016/j.actbio.2023.01.03010.1016/j.actbio.2023.01.030 ↗
60. 10.1021/bc500099v10.1021/bc500099v ↗
61. 10.5966/sctm.2015‐011510.5966/sctm.2015‐0115 ↗
62. 10.1126/sciadv.aay124010.1126/sciadv.aay1240 ↗
63. 10.1016/j.biomaterials.2009.03.02410.1016/j.biomaterials.2009.03.024 ↗
64. 10.1021/acs.nanolett.5b0031510.1021/acs.nanolett.5b00315 ↗
65. Hoffman A. S. · 2013
66. 10.1021/acs.biomac.6b0140710.1021/acs.biomac.6b01407 ↗
67. 10.1016/j.biomaterials.2023.12217910.1016/j.biomaterials.2023.122179 ↗
68. 10.1021/acsbiomaterials.9b0178910.1021/acsbiomaterials.9b01789 ↗
69. 10.1039/D1TB00178G10.1039/D1TB00178G ↗
70. 10.1039/D0BM02071K10.1039/D0BM02071K ↗
71. 10.1038/nature1303410.1038/nature13034 ↗
72. 10.1021/acsnano.2c0985510.1021/acsnano.2c09855 ↗
73. 10.1089/ten.tea.2016.016710.1089/ten.tea.2016.0167 ↗
74. 10.1002/adma.20250291910.1002/adma.202502919 ↗
75. 10.1016/j.actbio.2023.12.00110.1016/j.actbio.2023.12.001 ↗
76. 10.1002/smll.20247024410.1002/smll.202470244 ↗